GSK Investigational Site

Richmond Hill, Ontario L4C 1T6

0 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Dermatitis, Atopic, Neoplasms, Prostate, Psoriasis

Studies at this site

• Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis — Stopped early
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) — Completed
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis — Completed
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed